Improving Prostate Imaging: MRI alone or MRI + PSMA PET/CT?
A recent trial comparing MRI-guided biopsy to MRI plus PSMA PET/CT for prostate cancer found no significant difference in detecting clinically significant cancers. While combining imaging may reveal slightly more lesions, the benefit appears minimal and doesn’t outweigh added costs or complexity. keep reading
